What do systematic reviews say?

Intervention not reported

The intervention showed no clear difference in mortality (instead of overall survival)[2] (moderate certainty).

• Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission 2015 · Cochrane Headline outcomes only
  HR 1.05 [0.95, 1.16]
  5 studies · 1355 participants
  Moderate